However, the Pax5Prd*‐Jak2/+ mice still developed B‐ALL with a median survival of 178 days (Fig 5H) and thus lived on average 100 days longer than Pax5Jak2/+ mice (Fig 1F). This evidence concerns the gene JAK2 and precursor B-cell acute lymphoblastic leukemia.